Literature DB >> 28412709

The Association of Low Income with Functional Status and Disease Burden in German Patients with Rheumatoid Arthritis: Results of a Cross-sectional Questionnaire Survey Based on Claims Data.

Johanna Callhoff1,2, Andres Luque Ramos3,4, Angela Zink3,4, Falk Hoffmann3,4, Katinka Albrecht3,4.   

Abstract

OBJECTIVE: To assess the influence of income on self-reported disease and work productivity outcomes.
METHODS: Persons with rheumatoid arthritis (RA) diagnosis (International Classification of Diseases, 10th ed. codes M05/M06) on health insurance claims data in at least 2 quarters of 2013 were randomly selected. They were mailed questionnaires covering RA diagnosis, household income, functional capacity [Hannover functional status questionnaire (FFbH), 0-100], RA Impact of Disease questionnaire (RAID; 0-10), self-reported swollen joint count (SJC; 0-48), tender joint count (TJC; 0-50), and effect of RA on work productivity (change of work, fewer working hours, sick leave, application for disability pension, and others). Weighted multivariable linear regression models were used to assess the association between income and disease outcomes.
RESULTS: A total of 1492 persons of working age who confirmed RA diagnosis were available for analysis. The mean age was 55 years, 82% were women, and 74% were under rheumatologic care. A total of 27%, 52%, and 21% had a low (< €1500), medium (€1500-3200), and high monthly income (> €3200), respectively. Respondents with low income had the worst mean FFbH, RAID, SJC, and TJC values. This was confirmed in the regression model: mean FFbH low versus high income -8.65 (95% CI -9.72 to -7.58), RAID 0.73 (0.59-0.86), and SJC 3.47 (2.86-4.08). Sick leave (8.7%/3.5%/1.8%) and disability pension (18.1%/9.6%/6.9%) were more frequent in patients with low versus medium versus high income (p < 0.05).
CONCLUSION: The association of low income with a higher disease burden, more functional disability, and higher rates of work loss emphasizes the need to focus on these outcomes when choosing treatment strategies for patients in the lower income groups.

Entities:  

Keywords:  DISEASE BURDEN; EPIDEMIOLOGY; HEALTHCARE; RHEUMATOID ARTHRITIS

Mesh:

Year:  2017        PMID: 28412709     DOI: 10.3899/jrheum.160966

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  6 in total

Review 1.  [Reality of care for musculoskeletal diseases at the population level : Results of the PROCLAIR collaborative project. German version].

Authors:  J Callhoff; K Albrecht; F Hoffmann; D Poddubnyy; K-P Günther; A Zink
Journal:  Z Rheumatol       Date:  2019-10       Impact factor: 1.372

2.  Evaluation of C-Reactive Protein and Associated Factors Among Patients Suffering from Rheumatoid Arthritis at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia.

Authors:  Gashaw Dessie; Yewondwossen Tadesse; Birhanu Demelash; Solomon Genet; Tabarak Malik; Tadesse Asmamaw Dejenie
Journal:  Open Access Rheumatol       Date:  2021-08-21

Review 3.  Association between social deprivation and disease activity in rheumatoid arthritis: a systematic literature review.

Authors:  Mrinalini Dey; Amanda Busby; Helen Elwell; Heidi Lempp; Arthur Pratt; Adam Young; John Isaacs; Elena Nikiphorou
Journal:  RMD Open       Date:  2022-04

4.  Income and Other Contributors to Poor Outcomes in U.S. Patients with Sarcoidosis.

Authors:  Logan J Harper; Alicia K Gerke; Xiao-Feng Wang; Manuel L Ribeiro Neto; Robert P Baughman; Kelli Beyer; Marjolein Drent; Marc A Judson; Lisa A Maier; Leslie Serchuck; Noopur Singh; Daniel A Culver
Journal:  Am J Respir Crit Care Med       Date:  2020-04-15       Impact factor: 21.405

5.  Social determinants of health influence disease activity and functional disability in Polyarticular Juvenile Idiopathic Arthritis.

Authors:  William Daniel Soulsby; Nayimisha Balmuri; Victoria Cooley; Linda M Gerber; Erica Lawson; Susan Goodman; Karen Onel; Bella Mehta
Journal:  Pediatr Rheumatol Online J       Date:  2022-03-07       Impact factor: 3.054

6.  Sustained improvement in work outcomes in employed patients with rheumatoid arthritis during 2 years of adalimumab therapy: an observational cohort study.

Authors:  Frank Behrens; Hans-Peter Tony; Michaela Koehm; Eva C Schwaneck; Holger Gnann; Gerd Greger; Harald Burkhardt; Marc Schmalzing
Journal:  Clin Rheumatol       Date:  2020-03-23       Impact factor: 2.980

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.